Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
NCT ID: NCT05817799 Phase: PHASE2 Status: COMPLETED Enrollment: 83 Completion: 2023-07-10
Conditions
Hemodialysis Complication
Interventions
L-Carnitine 500Mg thrice daily, 1g L-Carnitine IV three times a week
Summary
OBJECTIVES
- To assess the levels of plasma carnitine in controls and hemodialysis patients.
- To give supplementary L-carnitine to study subjects for a duration of 5months.
- To compare the values of plasma carnitine before and after L carnitine supplementation.
- To assess the role of carnitine supplementation on biochemical and clinical parameters.
Primary Outcome
L-Carnitine levels in hemodialysis